Financial

The fresh capital will enable MDLIVE to continue its organic growth and expand its acquisition strategy to reach even more customers across the U.S.

The company will use the fresh capital to expand to 15 markets over 12 months; 3 VCs and numerous renowned angels provided the capital.

The company will use the funds to further scale production of the SVOne, develop additional products and services, and expand the team.

The company will use the fresh funds to enter new markets, expand support of its global customer base, and drive enhancements to its product.

The company, which will use the new money to expand its team of 20, is working on a wearable metabolic health tracker that should be released in early 2016.

The new money will be used to enter into the research and clinical diagnostics markets, and launch new platforms based on ACD's RNAscope technology.

Intermountain Healthcare, Healthbox and Tencent provided the capital, helping the company's efforts to enable genome-guided, individualized medicine.

The company will use the fresh capital to continue to grow its telehealth service, and will build out a sales team to procure additional corporate customers.

Temasek led the round according to the Financial Times, and the company (Hello) is now valued between $250 million and $300 million.

The company helps small doctor practices band together in so-called accountable care organizations (ACOs), enabled by the Affordable Care Act.